Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

Behaviour Research and Therapy

Volumn 124, Issue , 2020, Pages

  Hartmann, Jessica A ^a,b   Schmidt, Stefanie J ^c   McGorry, Patrick D ^a,b   Berger, Maximus ^a,b   Berger, Gregor E ^d   Chen, Eric Y H ^e   de Haan, Lieuwe ^f   Hickie, Ian B ^g   Lavoie, Suzie ^a,b   Markulev, Connie ^a,b   Mossaheb, Nilufar ^h   Nieman, Dorien H ^f   Nordentoft, Merete ⁱ   Polari, Andrea ^a,b   Riecher Rössler, Anita ^j   Schäfer, Miriam R ^a,b   Schlögelhofer, Monika ^h   Smesny, Stefan ^k   Thompson, Andrew ^a,b,l   Verma, Swapna K ^m   Yuen, Hok Pan ^a,b   Yung, Alison R ^a,b   Amminger, G Paul ^a,b   Nelson, Barnaby ^a,b   more..

^a THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF SYDNEY   (Australia)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j UNIVERSITY OF BASEL   (Switzerland)

^k JENA UNIVERSITY HOSPITAL   (Germany)

^l UNIVERSITY OF WARWICK   (United Kingdom)

^m INSTITUTE OF MENTAL HEALTH   (Singapore)

more..

Author keywords

Latent class growth analysis; Longitudinal; Psychosis; Symptom trajectories; Ultra high risk

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CASE MANAGEMENT; COGNITION; COGNITIVE BEHAVIORAL THERAPY; COGNITIVE BEHAVIOURAL CASE MANAGEMENT; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GENDER; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEGATIVE SYNDROME; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY; SUBSTANCE USE; DISEASE EXACERBATION; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 85075575815     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2019.103527     Document Type: Article

References (54)

1. Abdin, E., Chong, S.A., Vaingankar, J.A., Peh, C.X., Poon, L.Y., Rao, S., et al. Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period. PLoS One, 12, 2017, e0187141.
2. Addington, J., Case, N., Saleem, M.M., Auther, A.M., Cornblatt, B.A., Cadenhead, K.S., Substance use in clinical high risk for psychosis: A review of the literature. Early Intervention Psychiatry 8 (2014), 104–112.
3. Alqarni, A., McIntyre, K.J., Brown, S.H.J., Meyer, B.J., Mitchell, T.W., A high-throughput method for the analysis of erythrocyte fatty acids and the omega-3 index. Lipids 53 (2018), 1005–1015.
4. Andreasen, N.C., Scale for the assessment of negative symptoms (SANS). 1983, University of Iowa, Iowa City.
5. Austin, S.F., Mors, O., Budtz-Jorgensen, E., Secher, R.G., Hjorthoj, C.R., Bertelsen, M., et al. Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10 year follow-up study in the OPUS cohort. Schizophrenia Research 168 (2015), 84–91.
6. Barajas, A., Ochoa, S., Obiols, J.E., Lalucat-Jo, L., Gender differences in individuals at high-risk of psychosis: A comprehensive literature review. ScientificWorld Journal, 2015, 2015, 430735.
7. Barnett, J.H., Croudace, T.J., Jaycock, S., Blackwell, C., Hynes, F., Sahakian, B.J., et al. Improvement and decline of cognitive function in schizophrenia over one year: A longitudinal investigation using latent growth modelling. BMC Psychiatry, 7, 2007, 16.
8. Barnett, A.G., van der Pols, J.C., Dobson, A.J., Regression to the mean: What it is and how to deal with it. International Journal of Epidemiology 34 (2005), 215–220.
9. Carney, R., Yung, A.R., Amminger, G.P., Bradshaw, T., Glozier, N., Hermens, D.F., et al. Substance use in youth at risk for psychosis. Schizophrenia Research 181 (2017), 23–29.
10. Chang, W.C., Chu, A.O.K., Kwong, V.W.Y., Wong, C.S.M., Hui, C.L.M., Chan, S.K.W., et al. Patterns and predictors of trajectories for social and occupational functioning in patients presenting with first-episode non-affective psychosis: A three-year follow-up study. Schizophrenia Research 197 (2018), 131–137.
11. Cole, V.T., Apud, J.A., Weinberger, D.R., Dickinson, D., Using latent class growth analysis to form trajectories of premorbid adjustment in schizophrenia. Journal of Abnormal Psychology 121 (2012), 388–395.
12. Corcoran, C.M., Kimhy, D., Parrilla-Escobar, M.A., Cressman, V.L., Stanford, A.D., Thompson, J., et al. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychological Medicine 41 (2011), 251–261.
13. Fusar-Poli, P., Cappucciati, M., Borgwardt, S., Wood, S.W., Addington, J., Nelson, B., et al. Heterogeneity of psychosis risk within individuals at clinical high risk: A meta-analytical stratification. JAMA Psychiatry 73 (2016), 113–120.
14. Fusar-Poli, P., Van Os, J., Lost in transition: Setting the psychosis threshold in prodromal research. Acta Psychiatrica Scandinavica 127 (2012), 248–252.
15. van der Gaag, M., Nieman, D.H., Rietdijk, J., Dragt, S., Ising, H.K., Klaassen, R.M., et al. Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: A randomized controlled clinical trial. Schizophrenia Bulletin 38 (2012), 1180–1188.
16. Goldman, H.H., Skodol, A.E., Lave, T.R., Revising axis V for DSM-IV: A review of measures of social functioning. American Journal of Psychiatry 149 (1992), 1148–1156.
17. Harris, W.S., Von Schacky, C., The omega-3 index: A new risk factor for death from coronary heart disease?. Preventive Medicine 39 (2004), 212–220.
18. Hartmann, J.A., McGorry, P.D., Schmidt, S.J., Amminger, G.P., Yuen, H.P., Markulev, C., et al. Opening the black box of cognitive-behavioural case management in clients with ultra-high risk for psychosis. Psychotherapy and Psychosomatics 86 (2017), 292–299.
19. Hodgekins, J., Birchwood, M., Christopher, R., Marshall, M., Coker, S., Everard, L., et al. Investigating trajectories of social recovery in individuals with first-episode psychosis: A latent class growth analysis. The British Journal of Psychiatry 207 (2015), 536–543.
20. Hutton, P., Taylor, P.J., Cognitive behavioural therapy for psychosis prevention: A systematic review and meta-analysis. Psychological Medicine 44 (2014), 449–468.
21. Keefe, R.S., Goldberg, T.E., Harvey, P.D., Gold, J.M., Poe, M.P., Coughenour, L., The Brief assessment of cognition in schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research 68 (2004), 283–297.
22. Keefe, R.S., Harvey, P.D., Goldberg, T.E., Gold, J.M., Walker, T.M., Kennel, C., et al. Norms and standardization of the Brief assessment of cognition in schizophrenia (BACS). Schizophrenia Research 102 (2008), 108–115.
23. Levine, S.Z., Rabinowitz, J., Case, M., Ascher-Svanum, H., Treatment response trajectories and their antecedents in recent-onset psychosis: A 2-year prospective study. Journal of Clinical Psychopharmacology 30 (2010), 446–449.
24. Levine, S.Z., Rabinowitz, J., Faries, D., Lawson, A.H., Ascher-Svanum, H., Treatment response trajectories and antipsychotic medications: Examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial. Schizophrenia Research 137 (2012), 141–146.
25. Madsen, T., Karstoft, K.I., Secher, R.G., Austin, S.F., Nordentoft, M., Trajectories of suicidal ideation in patients with first-episode psychosis: Secondary analysis of data from the OPUS trial. Lancet Psychiatry 3 (2016), 443–450.
26. Markulev, C., McGorry, P.D., Nelson, B., Yuen, H.P., Schaefer, M., Yung, A.R., et al. NEURAPRO-E study protocol: A multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders. Early Intervention Psychiatry 11 (2017), 418–428.
27. Marques, T.R., Arenovich, T., Agid, O., Sajeev, G., Muthen, B., Chen, L., et al. The different trajectories of antipsychotic response: Antipsychotics versus placebo. Psychological Medicine 41 (2011), 1481–1488.
28. McGorry, P.D., Hartmann, J.A., Spooner, R., Nelson, B., Beyond the “at risk mental state” concept: Transitioning to transdiagnostic psychiatry. World Psychiatry 17 (2018), 133–142.
29. McGorry, P.D., Nelson, B., Goldstone, S., Yung, A.R., Clinical staging: A heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Canadian Journal of Psychiatry 55 (2010), 486–497.
30. McGorry, P.D., Nelson, B., Markulev, C., Yuen, H.P., Schafer, M.R., Mossaheb, N., et al. Effect of omega-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: The NEURAPRO randomized clinical trial. JAMA Psychiatry 74 (2017), 19–27.
31. Montgomery, S.A., Asberg, M., A new depression scale designed to be sensitive to change. The British Journal of Psychiatry 134 (1979), 382–389.
32. Morrison, A.P., French, P., Stewart, S.L., Birchwood, M., Fowler, D., Gumley, A.I., et al. Early detection and intervention evaluation for people at risk of psychosis: Multisite randomised controlled trial. BMJ, 344, 2012, e2233.
33. Muthen, B., Latent variable analysis: Growth mixture modeling and related techniques for longitudinal data. Kaplan, D., (eds.) Handbook of quantitative methodology for the social sciences, 2004, Sage, Newbury Park, CA.
34. Nelson, B., Amminger, G.P., Yuen, H.P., Markulev, C., Lavoie, S., Schafer, M.R., et al. Neurapro: A multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course. NPJ Schizophrenia, 4, 2018, 11.
35. Nelson, B., McGorry, P.D., Wichers, M., Wigman, J.T.W., Hartmann, J.A., Moving from static to dynamic models of the onset of mental disorder: A review. JAMA Psychiatry 74 (2017), 528–534.
36. Nelson, B., Yung, A.R., Psychotic-like experiences as overdetermined phenomena: When do they increase risk for psychotic disorder?. Schizophrenia Research 108 (2009), 303–304.
37. Nordon, C., Rouillon, F., Azorin, J.M., Barry, C., Urbach, M., Falissard, B., Trajectories of antipsychotic response in drug-naive schizophrenia patients: Results from the 6-month ESPASS follow-up study. Acta Psychiatrica Scandinavica 129 (2014), 116–125.
38. Nylund, K.L., Asparouhov, T., Muthén, B.O., Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Structural Equation Modeling 14 (2007), 535–569.
39. van Os, J., Guloksuz, S., A critique of the “ultra-high risk” and “transition” paradigm. World Psychiatry 16 (2017), 200–206.
40. van Os, J., Guloksuz, S., Vijn, T.W., Hafkenscheid, A., Delespaul, P., The evidence-based group-level symptom-reduction model as the organizing principle for mental health care: Time for change?. World Psychiatry 18 (2019), 88–96.
41. Polari, A., Lavoie, S., Yuen, H.P., Amminger, P., Berger, G., Chen, E., et al. Clinical trajectories in the ultra-high risk for psychosis population. Schizophrenia Research 197 (2018), 550–556.
42. Ram, N., Grimm, K.J., Methods and measures: Growth mixture modeling: A method for identifying differences in longitudinal change among unobserved groups. International Journal of Behavioral Development 33 (2009), 565–576.
43. Schennach, R., Meyer, S., Seemuller, F., Jager, M., Schmauss, M., Laux, G., et al. Response trajectories in “real-world” naturalistically treated schizophrenia patients. Schizophrenia Research 139 (2012), 218–224.
44. Schmidt, S.J., Lange, M., Schottle, D., Karow, A., Schimmelmann, B.G., Lambert, M., Negative symptoms, anxiety, and depression as mechanisms of change of a 12-month trial of assertive community treatment as part of integrated care in patients with first- and multi-episode schizophrenia spectrum disorders (ACCESS I trial). European Archives of Psychiatry and Clinical Neuroscience 268 (2018), 593–602.
45. van de Schoot, R., Sijbrandij, M., Winter, S.D., Depaoli, S., Vermunt, J.K., The GRoLTS-checklist: Guidelines for reporting on latent trajectory studies. Structural Equation Modeling: A Multidisciplinary Journal 24 (2016), 451–467.
46. Stain, H.J., Bucci, S., Baker, A.L., Carr, V., Emsley, R., Halpin, S., et al. A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial. Schizophrenia Research 176 (2016), 212–219.
47. Thompson, W.K., Savla, G.N., Vahia, I.V., Depp, C.A., O'Hara, R., Jeste, D.V., et al. Characterizing trajectories of cognitive functioning in older adults with schizophrenia: Does method matter?. Schizophrenia Research 143 (2013), 90–96.
48. Velthorst, E., Fett, A.J., Reichenberg, A., Perlman, G., van Os, J., Bromet, E.J., et al. The 20-year longitudinal trajectories of social functioning in individuals with psychotic disorders. American Journal of Psychiatry 174 (2017), 1075–1085.
49. Wechsler, D., Wechsler Adult intelligence scale-3rd edition manual. 1997, The Psychological Corporation, New York.
50. WHO ASSIST Working Group, The alcohol, smoking and substance involvement screening test (ASSIST): Development, reliability and feasibility. Addiction 97 (2002), 1183–1194.
51. Xie, H., McHugo, G.J., Drake, R.E., Subtypes of clients with serious mental illness and Co-occurring disorders: Latent-class trajectory analysis. Psychiatric Services 60 (2009), 804–811.
52. Yuen, H.P., Mackinnon, A., Hartmann, J., Amminger, G.P., Markulev, C., Lavoie, S., et al. Dynamic prediction of transition to psychosis using joint modelling. 2018.
53. Yung, A.R., Nelson, B., Thompson, A., Wood, S.J., The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid?. Schizophrenia Research 120 (2010), 1–6.
54. Yung, A.R., Yuen, H.P., McGorry, P.D., Phillips, L.J., Kelly, D., Dell'Olio, M., et al. Mapping the onset of psychosis: The comprehensive assessment of at-risk mental states. Australian and New Zealand Journal of Psychiatry 39 (2005), 964–971.